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Abstract A recombinant expression system was developed to
analyse sequence determinants involved in O-glycosylation of
proteins in mycobacteria. By expressing peptide sequences
corresponding to known glycosylation sites within a chimeric
lipoprotein construct, amino acids flanking modified threonine
residues were found to have an important influence on
glycosylation. The expression system was used to screen
mycobacterial sequences selected using a neural network
(NetOglyc) trained on eukaryotic O-glycoproteins. Evidence of
glycosylation was obtained for eight of 11 proteins tested. The
results suggest that sites involved in O-glycosylation of
mycobacterial and eukaryotic proteins share similar structural
features.
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1. Introduction
Post-translational modi¢cation of proteins by covalent at-
tachment of carbohydrate moieties is common amongst eu-
karyotes but, by comparison, relatively rare in bacteria. Bac-
terial glycoproteins were initially characterised from the S-
layer of the cell wall of archaebacteria [1], and their occur-
rence in eubacteria is now well-established. Several of the
best-characterised prokaryotic glycoproteins are expressed by
pathogens, prompting the suggestion that they might contrib-
ute to interactions with mammalian cells during infection [2].
Examples include pili present on the surface of pathogenic
Neisseria [3,4] and antigens secreted into the growth medium
of Mycobacterium tuberculosis [5^8]. Deglycosylation of a
45 kDa glycoprotein antigen of M. tuberculosis decreased its
immunogenicity, possibly as a consequence of reducing inter-
action with carbohydrate recognition receptors on antigen-
presenting cells [9], and mutagenesis of a proposed O-glyco-
sylation site in an M. tuberculosis 19 kDa antigen promoted
proteolytic conversion from a cell-associated lipoprotein to a
non-acylated secreted antigen [10]. The conversion between
acylated and non-acylated forms is of particular interest in
light of the recent observation that bacterial lipoproteins trig-
ger cytokine signalling via toll-like receptors on mammalian
cells [11,12]. In the context of the recent completion of the
M. tuberculosis genome sequence [13], we were interested in
developing techniques for the identi¢cation of further myco-
bacterial glycoproteins with a view to assessment of their pos-
sible role in infection. The aim of the present study was to
investigate the possibility of de¢ning common structural fea-
tures that might assist in the prediction of O-glycosylation
sites in mycobacterial proteins.
In contrast to the well-de¢ned motif for N-linked glycosyl-
ation sites (Asn-X-Ser/Thr), it has proved di⁄cult to de¢ne a
consensus sequence for O-glycosylation of eukaryotic pro-
teins. Strategies that have been used to address this question
include the development of in vitro assays using synthetic
peptides mixed with puri¢ed glycosyl transferases [14^16], re-
combinant expression systems measuring in vivo glycosylation
of peptide cassettes inserted in chimeric reporter proteins [17]
and the compilation of sequence data from known O-glyco-
proteins [18]. From these studies, it has been shown that gly-
cosylation sites are characterised by threonine or serine resi-
dues £anked by sequences rich in proline, glycine and alanine
residues. The £anking sequences were found to have an im-
portant, though complex e¡ect on glycosylation activity. A
neural network, NetOglyc, was developed as a predictive
tool by initial training on a set of almost 200 known O-gly-
cosylation sites [19]. Threonine residues implicated in O-gly-
cosylation of the M. tuberculosis 45 kDa [5] and 19 kDa [10]
antigens have a high predictive score using NetOglyc. To
evaluate applicability of the eukaryotic algorithm as a starting
point for the de¢nition of a mycobacterial O-glycosylation
motif, we have established a mycobacterial expression system,
analogous to the eukaryotic system described by Nehrke et al.
[17], in which we could assess the modi¢cation of peptide
cassettes inserted in a recombinant lipoprotein backbone.
2. Materials and methods
2.1. Construction of PhoA fusions
The mycobacterial expression vector pCAS was prepared by liga-
tion of the promoter region, signal sequence and two N-terminal
amino acids of the M. tuberculosis 19 kDa antigen [20] to the phoA
gene of Escherichia coli lacking its own signal sequence, using proce-
dures described previously [10]. A BamHI linker was included to
facilitate insertion of peptide cassettes for glycosylation analysis.
Three approaches were used to insert cassettes into pCAS. For
short inserts (up to 15 amino acids), complementary oligonucleotides
matching the appropriate mycobacterial sequences were designed with
£anking BamHI linkers and ligated into BamHI-digested pCAS, es-
sentially as described by Janssen and Tommassen [21]. For longer
inserts, 120 bp fragments were ampli¢ed from M. tuberculosis genomic
DNA by polymerase chain reaction (PCR). Cycling conditions (95‡C
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for 54 s, 68‡C for 30 s, 72‡C for 30 s; 25 cycles) were optimised using
forward and reverse oligonucleotide primers incorporating £anking
BamHI restriction sites. PCR products were subsequently digested,
puri¢ed and ligated into pCAS following standard cloning method-
ology [22].
Ligation mixtures were transformed in E. coli DH5K, grown in
Luria^Bertani (LB) broth or agar medium with selection in the pres-
ence of hygromycin (Boehringer Mannheim) at 250 Wg/ml, and plas-
mid preparations were obtained using standard methodology [22]. The
identity of each construct was con¢rmed by sequence analysis using
an ABI 310 Genetic Analyzer and ABI PRISM Dye Terminator Cycle
Sequencing Ready Reaction kits (Perkin Elmer Applied Biosystems
Division). Plasmids were subsequently introduced into Mycobacterium
smegmatis mc2/1-2c by electroporation, using mycobacteria grown in
LB broth or on agar medium, with 0.05% tyloxapol (Sigma) and
50 Wg/ml hygromycin [23]. For visualisation of the alkaline phospha-
tase activity of recombinant colonies, mycobacteria were grown on
similar plates supplemented with 5-bromo-4-chloro-3-indolyl-phos-
phate-p-toluidine (BCIP; Sigma) at 40 Wg/ml. Positive colonies were
dark blue.
2.2. Analysis of concanavalin A (ConA)-binding
For electrophoretic analysis, recombinant M. smegmatis cultures
were grown for 3 days in LB medium containing tyloxapol and hy-
gromycin, harvested by centrifugation, resuspended in 1/50 of the
original volume of phosphate-bu¡ered saline (PBS) and sonicated
on ice in bursts of 30 s over a 5 min period at 18 Wm amplitude
(Soniprep 150, MSE). Alternatively, bacteria from a single colony
were suspended in 200 Wl of PBS and sonicated. Sonicated prepara-
tions were boiled in the presence of sodium dodecyl sulphate (SDS)
and L-mercaptoethanol and samples (2^4 Wg total protein) were ana-
lysed by SDS^polyacrylamide gel electrophoresis, followed by transfer
to nitrocellulose membranes (Sartorius). The binding of peroxidase-
conjugated ConA (Sigma) and recognition by rabbit polyclonal anti-
bodies against PhoA (kindly provided by Juliano Timm, Institut Pas-
teur) were visualised as described previously [10]. Densitometric anal-
ysis of autoradiographs was performed with Scan Analysis software
(Biosoft) installed on a Macintosh computer using a Studio Scan II
£atbed scanner (Agfa).
2.3. DNA sequence analysis
Sequence information from the M. tuberculosis H37Rv genome
project was searched using the Prosite motif for prokaryotic lipopro-
teins (PS00013). Potential lipoproteins were further checked using the
Psort programme (http://www.psort.nibb.ac.jp) and open reading
frames predicted to encode lipoproteins were then analysed using
the NetOglyc neural network for the identi¢cation of O-linked glyco-
sylation sites (http://www.cbs.dtu.dk/netOglyc/) [19].
3. Results
3.1. A cassette system for identi¢cation of glycosylation sites
A DNA fragment encoding the mature form of E. coli
alkaline phosphatase (PhoA) was fused in frame with a frag-
ment encoding the signal sequence and two N-terminal amino
acids from the M. tuberculosis 19 kDa antigen, generating the
pCAS construct (Fig. 1A). Inclusion of the PhoA reporter
facilitated identi¢cation of positive transformants as blue col-
onies on BCIP agar. Two additional amino acids (glycine and
serine) were also present, as a result of insertion of a BamHI
linker between the two fragments. Introduction of this con-
struct into M. smegmatis resulted in the expression of a PhoA
fusion protein which showed no binding to the lectin ConA
(Fig. 1B, lane 1). As previously reported [10], inclusion of a
longer fragment of the 19 kDa N-terminal region-containing
threonine clusters at positions 13^15 and 19^20-generated a
ConA-positive fusion protein (Fig. 1B, lane 2). Mycobacte-
rium avium and Mycobacterium intracellulare express proteins
that share more than 70% identity with the M. tuberculosis 19
kDa antigen, but with serine-rich sequences in place of the
threonine-rich N-terminal region [24,25]. PhoA fusion pro-
teins containing the serine-rich sequences were both ConA-
negative in the recombinant expression system (Fig. 1B, lanes
3 and 4).
We next examined the e¡ect of inserting peptides spanning
glycosylated threonine residues from the M. tuberculosis
45 kDa antigen in the pCAS vector. The relevant sequences
were inserted using synthetic oligonucleotides designed to in-
clude BamHI linkers. Fig. 1 shows the sequences of the fusion
proteins and the results of ConA-binding analysis. Insertion
of 13 N-terminal amino acids from the 45 kDa sequence gen-
erated a ConA-positive fusion. Fusion proteins with shorter
inserts (5^10 amino acids) were ConA-negative, in spite of the
fact that each contained threonine-10, a residue known to be
glycosylated in the native protein [5]. Thus, the glycosylation
site from the 45 kDa antigen can be substituted for the equiv-
alent 19 kDa region in the chimeric lipoprotein but, as ob-
served in earlier site-directed mutagenesis experiments [10],
amino acids £anking the modi¢ed residues play an important
role in glycosylation.
3.2. Prediction of O-glycosylation sites in mycobacterial
lipoproteins
The ability to exchange glycosylation sequences between
mycobacterial proteins in the cassette expression system sug-
gests the possibility of a shared glycosylation motif. Threonine
residues within the positive 45 and 19 kDa sequences are
£anked by alanine and proline or glycine residues in a pattern
resembling that found in O-glycosylation sites in eukaryotic
proteins. The glycosylated threonines in the 45 kDa sequence
and the threonine residues implicated in ConA-binding of the
Fig. 1. Construction of pCAS fusions and assay for lectin-binding.
(A) shows the sequence of the pCAS vector, together with peptides
from 19 and 45 kDa antigens used to construct pCAS fusions. (B)
illustrates ConA-binding of the fusion constructs listed in (A). In
contrast to the threonine-rich N-terminal region of the M. tuberculo-
sis 19 kDa antigen, serine-rich sequences from M. avium and M. in-
tracellulare homologues were negative for ConA-binding. A peptide
spanning a known glycosylation site of the 45 kDa antigen was pos-
itive for ConA-binding, dependent on inclusion of appropriate
£anking residues.
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19 kDa antigen each had a high predictive score when
screened using the NetOglyc algorithm for eukaryotic O-gly-
cosylation sites [19]. To test whether the analogy with the
eukaryotic consensus could be extended to further mycobac-
terial proteins, we used NetOglyc to select additional pre-
dicted glycosylation sequences from the M. tuberculosis ge-
nome [13].
Threonine residues with the potential to act as glycosylation
sites occur at a frequency of approximately 10 per 1000 amino
acids within open reading frames in the M. tuberculosis ge-
nome. To restrict the NetOglyc screen to a manageable out-
put, and with the aim of further exploring the glycosylation^
acylation link observed with the 19 kDa antigen [10], an initial
search was focused on lipoproteins. From 98 lipoprotein se-
quences in the M. tuberculosis genome (identi¢ed by the pres-
ence of a prokaryotic lipoprotein lipid attachment motif),
35 had two or more positively-predicted threonines within
the N-terminal 40 amino acids. These are listed in Table 1.
3.3. Expression of predicted glycosylation sites
To evaluate the predictive value of the NetOglyc analysis,
sequences from a subset of the predicted glycosylated lipopro-
teins were expressed in the PhoA cassette system and assayed
for ConA-binding. Two PhoA fusion constructs were pre-
pared using fragments from PhoS1, the 38 kDa antigen [26].
38S-PhoA contained amino acids 15^31, spanning the NetO-
glyc-predicted threonines at positions 20, 21 and 28, as an
insert in pCAS. 38L-PhoA contained a longer fragment
(43 amino acids) from the N-terminal region, as well as the
native signal sequence of the 38 kDa protein. As had been
observed in the case of the 45 kDa antigen, the longer fusion
protein bound ConA but the short construct was negative
(Fig. 2A). A further eight constructs were prepared from
open reading frames containing from two to six NetOglyc-
positive threonines. In each case the entire 40 amino acid
N-terminal fragment was expressed in pCAS, with the level
Table 1
M. tuberculosis genes encoding lipoproteins with predicted glycosylation sites
Genome location Name Description NetOglyc hits
Rv0583c LpqN similar to M. kansasii antigen MK35 13
Rv0344c LpqJ unknown lipoprotein 10
Rv3763 LpqH 19 kDa antigen 7
Rv1228 LpqX unknown lipoprotein 6
Rv2270 LppN unknown lipoprotein 6
Rv1911c LppC lipoprotein, similar to Rv1910c 5
Rv2341 LppQ unknown lipoprotein 5
Rv1016c LpqT similar to M. kansasii antigen MK35 5
Rv1899c LppD 4-hydroxybutyrate dehydrogenase 4
Rv2873 MPT83 antigen, related to MPT70 4
Rv1899c LpqI beta-hexosaminidase precursor 4
Rv0835 LpqQ unknown lipoprotein 4
Rv0838 LpqR D-Ala/D-Ala dipeptidase 4
Rv1166 LpqW antigen ORFA2-898 4
Rv1252c LprE unknown, similar to Rv3483c 4
Rv1922 probable penicillin-binding protein 4
Rv0432 SodC Cu^Zn superoxide dismutase precursor 4
Rv2672 protease, similar to Rv2223c,2224c 3
Rv2330c LppP unknown lipoprotein 3
Rv3006 LppZ unknown lipoprotein 3
Rv0934 PhoS1 38 kDa antigen, phosphate uptake 3
Rv0237 LppI unknown lipoprotein 3
Rv1677 DsbF thiol:disulphide interchange similar to antigen MPT53 3
Rv2394 GgtB Q-glutamyltranspeptidase precursor 3
Rv0411c GlnH glutamine-binding protein 2
Rv2068c BlaC class A L-lactamase 2
Rv1881c LppE unknown lipoprotein 2
Rv2116 LppK unknown lipoprotein 2
Rv1541c LprI unknown lipoprotein 2
Rv2138 LppL unknown lipoprotein 2
Rv0399c LpqK possible penicillin-binding protein 2
Rv0132c putative oxidoreductase 2
Rv1274 LprB unknown lipoprotein 2
Rv1368 LprF lipoprotein, similar to LprA, LprG, LppX 2
Rv1418 LprH unknown lipoprotein 2
The number of NetOglyc-positive threonine residues is shown for the ¢rst 40 amino acids after the predicted acylation site.
For entries shown in bold, there is evidence of post-translational modi¢cation of expressed products.
Fig. 2. Testing of NetOglyc predictions by ConA-binding. Sequences
predicted using NetOglyc were expressed in the pCAS vector and
screened for ConA-binding. (A) shows results with sequences from
PhoS1, the 38 kDa antigen. pCAS-38i (lane 1) contained 42 amino
acids from the N-terminus of the protein. Lanes 2 and 3 show nega-
tive constructs with shorter inserts: pCAS-38ii (PETGAGAGT-
VATTP) and pCAS-38iii (GAGTVATTPASSPVTLA). (B) illustrates
pCAS fusions containing 40 amino acid inserts from predicted lipo-
proteins. Lane 1, pCAS-19-TB (positive control); 2, LppN; 3,
SodC; 4, LppQ; 5, LprB; 6, LpqT; 7, GlnH and 8, LprI. Samples
were considered negative when ConA-binding (assessed by scanning
densitometry) was less than 10% of that in the positive control.
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of expression of each fusion assessed by Western blot analysis
with an antibody to PhoA (data not shown). Strong ConA-
binding was observed with four of the fusions (Fig. 2B). A
¢fth fusion, LprI, was expressed at low level and showed weak
but detectable binding (Fig. 2B, lane 8). The remaining three
fusions were clearly detectable by PhoA staining but failed to
bind ConA. In a separate study (unpublished results in col-
laboration with S. Michell and G. Hewinson), the amino-ter-
minal region of MPT83 was found to confer ConA-binding
when expressed in pCAS. Overall, from 11 of the lipoprotein
sequences predicted by NetOglyc, eight were found to be
ConA-positive in the pCAS expression system (Fig. 3).
4. Discussion
Although abundant in eukaryotic cells, glycoproteins are
rare in bacteria and relatively little is known about the mech-
anisms and speci¢city of glycosylation in prokaryotes. In the
present study we have tested whether a neural network trained
on eukaryotic O-glycoproteins can be applied in the study of
protein glycosylation in mycobacteria. The results indicate
that the eukaryotic neural network does provide a useful
starting point for characterisation of mycobacterial glycosyl-
ation, with the majority of predicted regions proving positive
in a lipoprotein expression system assessed by lectin-binding.
This ¢nding suggests that, despite the absence of an organised
Golgi structure in prokaryotes, the fundamental enzymology
of O-glycosylation in mycobacteria probably resembles that in
eukaryotic cells. The absence of glycosylation in constructs in
which serine-rich regions replaced the threonine-rich domain
of the 19 kDa antigen suggest that, at least in the M. smeg-
matis expression system, threonine is the preferred residue for
mycobacterial O-glycosylation.
There is considerable scope for further optimisation of a
predictive approach for bacterial glycoprotein sequences. Sev-
eral of the tested sequences were negative and the high fre-
quency of M. tuberculosis open reading frames containing
potential glycosylation sites vastly exceeds the likely number
of glycoproteins. It can be anticipated that training of the
neural network on bacterial O-glycoprotein sites would signif-
icantly enhance predictive potential, although this will be de-
pendent on signi¢cant expansion of the currently available
structural database for bacterial glycoproteins. Recombinant
products of expression systems such as the pCAS vector de-
scribed in the present study may provide a useful source of
substrates for the necessary structural analysis. Regions of the
protein surrounding potentially modi¢ed residues clearly have
a major impact on glycosylation. The length of the peptide
insert had a critical in£uence in the pCAS expression system,
with peptides below 10 amino acids showing no evidence of
modi¢cation, in spite of the inclusion of a NetOglyc-positive
motif. The protein framework used for expression was also
important. When 19 kDa peptides positive in pCAS fusions
were cloned in the permissive loop of M. tuberculosis super-
oxide dismutase [27], there was no evidence of glycosylation,
as assessed by lectin-binding or by mass spectrometry analysis
(data not shown). It is probable that protein glycosylation in
mycobacteria depends not just on the presence of an appro-
priate motif, but also on localisation of the protein to a par-
ticular part of the bacterial cell.
Sequence alignments of the predicted glycosylated lipopro-
teins with related open reading frames from M. tuberculosis
itself or with functional homologues from other bacteria fre-
quently highlight the threonine-rich domain as a divergent
region. This is particularly clear when comparing MPT83
with the related MPT70 antigen, with the threonine-rich re-
gion standing out as an apparent 32 amino acid insertion (Fig.
4). Glycosylation domains in M. tuberculosis may have
evolved together with gene duplication as a means for express-
ing functionally related proteins di¡ering in their intracellular
location. Conversion between cell-associated and secreted
forms has previously been documented for lipoproteins pro-
duced by Gram-positive bacteria [28,29] and glycosylation
may provide a means for regulating this in mycobacteria.
The possible role of glycosylation in host cell interactions is
illustrated by links between the panel of predicted glycopro-
teins and the immune repertoire. In addition to the 19 kDa
antigen, the NetOglyc search identi¢ed PhoS1 (the 38 kDa
antigen of M. tuberculosis [26]) and MPT83, an antigen ex-
tensively analysed in the context of bovine tuberculosis [30].
The thiol-disulphide exchange protein, DsbF, is closely related
to the previously described antigen MPT53 from M. tuber-
culosis [31] and LpqW was recently identi¢ed during a screen
Fig. 3. Summary of NetOglyc predictions and ConA-binding. Pep-
tide sequences containing potential glycosylation sites predicted by
NetOglyc were expressed as pCAS fusions and tested for lectin-
binding. Sequences are shown on the top line, with threonine resi-
dues matching the NetOglyc prediction indicated on the lower line.
Fig. 4. Sequence alignment of MPT83 and MPT70. The threonine-
rich region predicted as a potential glycosylation site in MPT83 has
no counterpart in the closely related MPT70 antigen.
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for mycobacterial secreted antigens [32]. LpqN and LpqT
show sequence similarity both to each other and to a prom-
inent antigen from Mycobacterium kansasii [33].
In summary, this study highlights similarities between O-
glycosylation of proteins in bacterial and eukaryotic cells.
The use of a predictive algorithm in combination with a re-
combinant expression system provides an approach to the
identi¢cation of mycobacterial O-glycoproteins, generating re-
sults consistent with the existence of a family of glycosylated
lipoproteins in M. tuberculosis.
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